Invests in categories: AIAutomationBioTechCellEngineeringDeliverySystemsHealthTechHematologyMedicalDeviceMedicalDevicesTechnology
Investment Stage: Series B
Portfolio 13
Show more
Persons 3
| Date | First Name | Last Name | Title | LinkedIn | Email | Location |
| - | Jay | Mohr | General Pa... | | - | - |
| - | Christophe... | D. Hillyer... | General Pa... | | - | - |
| - | Meg | Wood, MPH | Managing D... | | - | - |
Mentions in press and media 1
| Date | Title | Description |
| 09.06.2026 | City Therapeutics Raises $99.5M in Series B Funding | City Therapeutics, Inc., a Cambridge, MA-based biopharmaceutical company developing RNA interference (RNAi)-based medicines, raised $99.5M in Series B funding.
The round was led by Viking Global Investors and Sofinnova Investments with part... |
Reviews 0
